LBA-1 Phase 3 APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) vs gemcitabine (Gem) alone in patients with resected pancreatic cancer (PC): Updated 5-year overall survival
Titel:
LBA-1 Phase 3 APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) vs gemcitabine (Gem) alone in patients with resected pancreatic cancer (PC): Updated 5-year overall survival
Auteur:
Tempero, M. O'Reilly, E. Van Cutsem, E. Berlin, J. Philip, P. Goldstein, D. Tabernero, J. Borad, M. Bachet, J. Parner, V. Tebbutt, N. Chua, Y. Corrie, P. Harris, M. Taieb, J. Burge, M. Kunzmann, V. Zhang, G. McGovern, D. Marks, H. Biankin, A. Reni, M.